drug
as of 2026-07-01Inhaled Loxapine 10 mg
inhaled Loxapine 10 mgInhaled loxapine 10 mg
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Alexza Pharmaceuticals, Inc.
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
3
Staccato Loxapine in Agitated Patients With Schizophrenia
NCT00628589Phase 3Completed
Staccato Loxapine in Agitation (Proof of Concept)
NCT00369577Phase 2Completed
Staccato Loxapine Single Dose PK
NCT00444028Phase 1Completed
KOLs & investigators
3
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
KOL
Daniel Zimbroff, MD
personKOL score —
Randall Stoltz, MD
personKOL score —
Robert S Fishman, MD
personKOL score —